Healthcare -
Biotechnology - NASDAQ - US
$ 0.7109
-0.878 %
$ 64.4 M
Market Cap
-0.39
P/E
VRCA - COST OF REVENUE
Cost of Revenue VRCA - Verrica Pharmaceuticals Inc.
746 K
LAST VALUE
25.72%
2 YEAR CAGR
105.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR